Literature DB >> 22329358

LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile.

X Hu1, K R Steffensen, Z-Y Jiang, P Parini, J-Å Gustafsson, M Gåfvels, G Eggertsen.   

Abstract

OBJECTIVES: Liver X receptors (LXRs) are essential for the regulation of intestinal cholesterol absorption. Because two isoforms exist, LXRα and LXRβ, with overlapping but not identical functions, we investigated whether LXRα and LXRβ exert different effects on intestinal cholesterol absorption.
DESIGN: Wild-type (WT), LXRα(-/-) and LXRβ(-/-) mice were fed control diet, 0.2% cholesterol-enriched diet or 0.2% cholesterol-enriched diet plus the LXR agonist GW3965.
RESULTS: When fed a control diet, all three genotypes showed similar levels of cholesterol absorption. Of interest, a significant increase in cholesterol absorption was found in the LXRα(-/-) mice, but not in the WT or LXRβ(-/-) animals, when fed a diet enriched with 0.2% cholesterol or 0.2% cholesterol + GW3965. Reduced faecal neutral sterol excretion and a hydrophobic bile acid profile were also observed in LXRα(-/-) mice. Greater increases in the apolipoprotein (apo)B-containing lipoproteins in serum were seen in the LXRα(-/-) mice. A 0.2% cholesterol +GW3965 diet suppressed intestinal Npc1l1 protein expression to the same extent for all genotypes, while Abca1 and Abcg5 were elevated to the same degree.
CONCLUSIONS: In the intestine, LXRα and LXRβ seem to exert similar effects on expression of cholesterol-transporting proteins such as Npc1l1. Selective activation of LXRβ may generate effects such as increased cholesterol absorption and elevated serum levels of apoB-containing lipoproteins, which seem to be counteracted by LXRα. Therefore, an intestinal LXRβ-specific pathway might exist in terms of cholesterol transportation in addition to the main pathway.
© 2012 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22329358     DOI: 10.1111/j.1365-2796.2012.02529.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  10 in total

Review 1.  Intestinal nuclear receptors in HDL cholesterol metabolism.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  J Lipid Res       Date:  2014-07-28       Impact factor: 5.922

2.  Morin, a novel liver X receptor α/β dual antagonist, has potent therapeutic efficacy for nonalcoholic fatty liver diseases.

Authors:  Ming Gu; Yu Zhang; Chuhe Liu; Dongshan Wang; Li Feng; Shengjie Fan; Baican Yang; Qingchun Tong; Guang Ji; Cheng Huang
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

3.  The oxysterol receptor LXRβ protects against DSS- and TNBS-induced colitis in mice.

Authors:  T Jakobsson; L-L Vedin; T Hassan; N Venteclef; D Greco; M D'Amato; E Treuter; J-Å Gustafsson; K R Steffensen
Journal:  Mucosal Immunol       Date:  2014-05-07       Impact factor: 7.313

4.  LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.

Authors:  Kristina Kannisto; Mats Gåfvels; Zhao-Yan Jiang; Katharina Slätis; Xiaoli Hu; Carl Jorns; Knut R Steffensen; Gösta Eggertsen
Journal:  Lipids       Date:  2013-10-27       Impact factor: 1.880

5.  Chronic Activation of Liver X Receptor Sensitizes Mice to High Cholesterol Diet-Induced Gut Toxicity.

Authors:  Wojciech G Garbacz; Hirdesh Uppal; Jiong Yan; Meishu Xu; Songrong Ren; Donna B Stolz; Min Huang; Wen Xie
Journal:  Mol Pharmacol       Date:  2018-07-25       Impact factor: 4.436

Review 6.  Liver X receptors in lipid metabolism: opportunities for drug discovery.

Authors:  Cynthia Hong; Peter Tontonoz
Journal:  Nat Rev Drug Discov       Date:  2014-05-16       Impact factor: 84.694

7.  Role of Intestinal LXRα in Regulating Post-prandial Lipid Excursion and Diet-Induced Hypercholesterolemia and Hepatic Lipid Accumulation.

Authors:  Tibiábin Benítez-Santana; Sarah E Hugo; Amnon Schlegel
Journal:  Front Physiol       Date:  2017-05-09       Impact factor: 4.566

8.  Ouabagenin is a naturally occurring LXR ligand without causing hepatic steatosis as a side effect.

Authors:  Satoru Tamura; Maiko Okada; Shigeaki Kato; Yasuharu Shinoda; Norifumi Shioda; Kohji Fukunaga; Kumiko Ui-Tei; Minoru Ueda
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

9.  Transcriptional control of intestinal cholesterol absorption, adipose energy expenditure and lipid handling by Sortilin.

Authors:  Sumihiko Hagita; Maximillian A Rogers; Tan Pham; Jennifer R Wen; Andrew K Mlynarchik; Masanori Aikawa; Elena Aikawa
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379

Review 10.  Molecular Pathways Underlying Cholesterol Homeostasis.

Authors:  Milessa Silva Afonso; Roberta Marcondes Machado; Maria Silvia Lavrador; Eder Carlos Rocha Quintao; Kathryn J Moore; Ana Maria Lottenberg
Journal:  Nutrients       Date:  2018-06-13       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.